Top news of the week: 26.01.2022.
Companies And Industries
Cancer Biotech Boosts Funding and Names New CEO
The funds will be used to advance the firm's precision oncology research efforts and pipeline, particularly those involving the creation of alteration-specific therapies.
New Partnerships for Cutting Edge R&D Announced
Biotech companies are partnering with other biotech companies to combine their cutting-edge technology platforms in hopes of opening up new avenues for drug development.
Tennis Star Bets on a Grand Slam as 80% Shareholder in Danish Biotech
World tennis superstar Novak Djokovic reportedly has an 80% stake in QuantBioRes that's currently working on finding a treatment, not a vaccine, for COVID-19.
Psychedelic Biotech Takes SPAC Track to Nasdaq
Psychedelic-focused drug company Eleusis is merging with Silver Spike Acquisition Corp. II, a special purposes acquisition company, and heading to the Nasdaq with a combined enterprise ...
Biotech stocks are a dumpster fire. An analyst explains what’s going on
What's ailing biotech stocks lately? An analyst offers some explanations.
Does the world need more COVID-19 vaccines? These companies think there's still room for improvement
The ultimate COVID-19 vaccine will be able to tackle all emerging coronavirus strains, easy to store and quick to manufacture. And yes, there's still time for the stragglers who were beaten ...
Foresite Labs Hatches Big-Data-Driven Companies Destined to Shake up Healthcare
Such a deep, data-driven approach is enabling precision medicine, in particular, which is expanding from oncology to autoimmune diseases and other conditions.
AstraZeneca success torpedoes PCI's pivotal plan, crushing stock
The shock waves caused by the success of AstraZeneca’s TOPAZ-1 clinical trial have reached Norway. After reviewing the results, PCI Biotech has decided to scrap its own pivotal advanced ...